lenvatinib

Superiority:

4-[3-Chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-6-quinolinecarboxamide

甲磺酸仑伐替尼（乐伐替尼）N-1 中间体

lenvatinib Mesylate N-1 intermediate

Lenvatinib base

Lenvatinib

CAS:417716-92-8

纯度：98%

Purity:Not less than 98%

Jinan Xinke Pharmaceutical Science and Technology Co., Ltd. ( XKPHARM ) is an innovation driven company, headquartered in Jinan city, Shandong province, China and focus on the researching, manufacturing and marketing of high value added APIs and their intermediates.

XKPHARM has set up a modern R&D center in High-Tech Industrial Development Zone of Jinan city, which covers over 1000 square meters and owns a professional team. Our R&D center specialized in research and development of cutting-edge information and technology, thus providing a platform for the company's sustainably developing market competition.

We committed to continuously improving the quality management system throughout the whole process of procurement, production, testing and sales. Through effective process control and quality management of system specification, we committed to creating the maximum value for our customers while meeting different customer needs.

Our plant and infrastructure are designed in accordance with the latest domestic and international standards, and equipped with advanced production equipment, and the corresponding reactors, condensers, vacuum pumps and other equipments are selected according to advanced technology needs, which can meet the needs of different response types of equipment.

Now our competitive products include Tenofovir alafenamide, Obeticholic acid, Safinamide, Axitinib, Donepezil, and their intermediates. And more promising products in our pipeline. We always hold on our own special field and stick to win the trust of customers with better quality and service. We will work hard to innovate and manufacture quality products, promoting the growth of China pharmaceuticals industry.